Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-ci Cai

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 1, 2009
[13C breath tests: a useful tool to quantify hepatic reserve function]Xin-hua Qu, Xiao-lu Huang, Ming-ci Cai, et al.
Cell Communication and Signaling : CCS|December 23, 2025
XPO1 inhibitor selinexor enhances the apoptotic effect of azacitidine in T-cell lymphoma with TET2/RHOA mutations via JAK3/STAT3 axisTing-Ting Xu, Ming-Ci Cai, Shu Cheng, et al.
Cell Reports. Medicine|February 13, 2024
Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypesYao-Hui Huang, Yu-Ran Qiu, Qun-Ling Zhang, et al.
The Lancet Regional Health. Western Pacific|August 23, 2024
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trialMing-Ci Cai, Shu Cheng, Hong-Mei Jing, et al.
Oncogene|June 29, 2026
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signalingCong Wang, Ming-Ci Cai, Shu Cheng, et al.
Blood Advances|January 21, 2026
Serum free fatty acid promotes tumor progression and predicts golidocitinib sensitivity in peripheral T-cell lymphomaYao Qin, Pan Hui Xia, Yao-Hui Huang, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
World Journal of Gastroenterology|February 10, 2010
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysisXin-Hua Qu, Xiao-Lu Huang, Ping Xiong, et al.
Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 1, 2009
[13C breath tests: a useful tool to quantify hepatic reserve function]Xin-hua Qu, Xiao-lu Huang, Ming-ci Cai, et al.
Cell Communication and Signaling : CCS|December 23, 2025
XPO1 inhibitor selinexor enhances the apoptotic effect of azacitidine in T-cell lymphoma with TET2/RHOA mutations via JAK3/STAT3 axisTing-Ting Xu, Ming-Ci Cai, Shu Cheng, et al.
Cell Reports. Medicine|February 13, 2024
Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypesYao-Hui Huang, Yu-Ran Qiu, Qun-Ling Zhang, et al.
The Lancet Regional Health. Western Pacific|August 23, 2024
Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trialMing-Ci Cai, Shu Cheng, Hong-Mei Jing, et al.
Oncogene|June 29, 2026
LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signalingCong Wang, Ming-Ci Cai, Shu Cheng, et al.
Blood Advances|January 21, 2026
Serum free fatty acid promotes tumor progression and predicts golidocitinib sensitivity in peripheral T-cell lymphomaYao Qin, Pan Hui Xia, Yao-Hui Huang, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
World Journal of Gastroenterology|February 10, 2010
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysisXin-Hua Qu, Xiao-Lu Huang, Ping Xiong, et al.
Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Pageof 1